Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for prevention of gallstones after bariatric surgery
NL-OMON58854Phase 4Not yet recruiting
- Sponsor
- Spaarne Gasthuis
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of atorvastatin in cholelithiasis (2 arms), sponsored by Spaarne Gasthuis. Primary endpoint: Incidence of gallstone formation. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on NL-OMON58854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58854.